{"database": "lobbying", "table": "lobbying_activities", "rows": [[1453600, "542d0db4-9fbb-4010-860d-490ebeca1092", "Q3", "BROWN RUDNICK LLP", 287895, "PRIME THERAPEUTICS", 2013, "third_quarter", "PHA", "HR 460: Patients' Access to Treatments Act of 2013", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2013-10-18T15:43:12.483000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1453600"], "units": {}, "query_ms": 10.203245037700981, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}